99,165.06 +463.90 (+0.47%)| 1M | 3M | YTD | 1Y | 2Y |
| +3.45% | +8.60% | +17.92% | +22.41% | +26.31% |
Bringing its unique investor proposition to market, Atterbury Acquisitions Limited (Attacq) yesterdya listed on the Main Board of the JSE, under the Real Estate - Real Estate Holdings and Development sector, with the short code “ATT”.
GlaxoSmithKline today announced it has reached agreement to sell its thrombosis brands, Arixtra® and Fraxiparine®, and the Notre-Dame de Bondeville (NDB) manufacturing site to The Aspen Group (Aspen), the South African pharmaceuticals company, for £0.7 billion in cash, of which £0.1 billion relates to inventory. The agreement is a further example of GSK’s commitment to increase focus on products with the most growth potential and the delivery of its late-stage pipeline.
After a year of bearish commentary on South Africa's economy, following waves of industrial strike action and negative ratings outlook on its sovereign debt, it's great to see its securities exchange and financial markets still producing a world-class performance.
Barclays Africa and Absa have today announced that their plans to combine the two businesses and create Barclays Africa Group Limited have taken a major step forward.
 | BRVM-CI | 310.89 | -0.12% | 31/07 |
 | BSE DCI | 10,498.75 | - | 31/07 |
 | DSE ASI | 2,449.58 | +0.77% | 31/07 |
 | EGX 30 | 34,198.00 | +1.00% | 31/07 |
 | GSE-CI | 6,992.29 | +3.19% | 31/07 |
 | JSE ASI | 99,165.06 | +0.47% | 29/07 |
 | LuSE ASI | 21,041.02 | +0.37% | 31/07 |
 | MASI | 19,634.87 | +0.97% | 31/07 |
 | MSE ASI | 386,281.85 | +0.97% | 31/07 |
 | NGX ASI | 139,863.52 | +0.42% | 31/07 |
 | NSE ASI | 160.22 | -2.11% | 31/07 |
 | NSX OI | 1,785.05 | -0.13% | 29/07 |
 | RSE ASI | 150.43 | +0.03% | 31/07 |
 | SEM ASI | 2,163.70 | +0.27% | 31/07 |
 | TUNINDEX | 11,855.80 | -0.16% | 28/07 |
 | USE ASI | 1,357.51 | +1.42% | 31/07 |
 | ZSE ASI | 205.71 | +1.82% | 31/07 |
